Cargando…
The role of histone lysine methyltransferase NSD3 in cancer
The growing number of findings demonstrate that nuclear receptor suppressor of variegation, enhancer of zeste, and trithorax domain-containing 3 (NSD3) is amplified and overexpressed in multiple cancer types. Nevertheless, the biological roles of NSD3 in carcinogenesis have not been well understood....
Autores principales: | Han, Xu, Piao, Lianhua, Zhuang, Qianfeng, Yuan, Xiaofeng, Liu, Zhiwei, He, Xiaozhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038882/ https://www.ncbi.nlm.nih.gov/pubmed/30013365 http://dx.doi.org/10.2147/OTT.S166006 |
Ejemplares similares
-
Silencing of histone methyltransferase NSD3 reduces cell viability in osteosarcoma with induction of apoptosis
por: Liu, Zhiwei, et al.
Publicado: (2017) -
Knockdown of NSD2 Suppresses Renal Cell Carcinoma Metastasis by Inhibiting Epithelial-Mesenchymal Transition
por: Han, Xu, et al.
Publicado: (2019) -
The Target of the NSD Family of Histone Lysine Methyltransferases Depends on the Nature of the Substrate
por: Li, Yan, et al.
Publicado: (2009) -
NSD2 Promotes Renal Cancer Progression Through Stimulating Akt/Erk Signaling
por: Han, Xu, et al.
Publicado: (2020) -
Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?
por: Krossa, Imène, et al.
Publicado: (2022)